Literature DB >> 16350412

Transformation assays for HPV oncoproteins.

Paola Massimi1, Lawrence Banks.   

Abstract

A cornerstone of human papillomavirus (HPV) research was the demonstration that those HPV types associated with the development of cervical cancer encode two potent oncoproteins, while those HPV types associated with only benign lesions do not. Thus both HPV-16 E6 and E7 will transform established rodent cells and will efficiently cooperate with other activated oncogenes in the transformation of primary rodent cells. In addition, the virus also encodes for the E5 oncoprotein, which also possesses a weaker transforming activity in established rodent cells. In this chapter we describe how the transforming activities of the HPV oncoproteins can be assessed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16350412     DOI: 10.1385/1-59259-982-6:381

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  4 in total

1.  Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation.

Authors:  Biljana Todorovic; Paola Massimi; Katherine Hung; Gary S Shaw; Lawrence Banks; Joe S Mymryk
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

Review 2.  Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.

Authors:  T O Garnett; P J Duerksen-Hughes
Journal:  Arch Virol       Date:  2006-07-27       Impact factor: 2.574

3.  Dissection of the C-terminal region of E1A redefines the roles of CtBP and other cellular targets in oncogenic transformation.

Authors:  M J Cohen; A F Yousef; P Massimi; G J Fonseca; B Todorovic; P Pelka; A S Turnell; L Banks; J S Mymryk
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

4.  Oncogenic comparison of human papillomavirus type 58 E7 variants.

Authors:  Priscilla Ty Law; Siaw Shi Boon; Chenghua Hu; Raymond Wm Lung; Grace Py Cheung; Wendy Cs Ho; Zigui Chen; Paola Massimi; Miranda Thomas; David Pim; Lawrence Banks; Paul Ks Chan
Journal:  J Cell Mol Med       Date:  2018-12-21       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.